SomnoMed makes and markets a number of non-invasive treatments for sleep-related breathing disorders, including obstructive sleep apnea. The company’s lead product, SomnoDent™, was designed and developed in Australia and now provides a medical oral appliance therapy for over 350,000 patients in 28 countries.
SomnoMed is focused on growing the business internationally and leading the oral appliance market in the treatment of sleep apnea. It is re-investing revenues to build the foundations for long-term growth including sales channels, product innovation, clinical research and education. This includes the creation of 50 direct-to-customer treatment centres in the US as well as manufacturing and support facilities worldwide.